Research ExplorerPublications2018 international consensus meeting on musculoskeletal infe...

2018 international consensus meeting on musculoskeletal infection: Summary from the Biofilm Workgroup and consensus on Biofilm related Musculoskeletal Infections

Standard

2018 international consensus meeting on musculoskeletal infection: Summary from the Biofilm Workgroup and consensus on Biofilm related Musculoskeletal Infections. / Saeed, Kordo; McLaren, Alex C; Schwarz, Edward M; Antoci, Valentin; Arnold, William V; Chen, Antonia F; Clauss, Martin; Esteban, Jaime; Gant, Vanya; Hendershot, Edward; Hickok, Noreen; Higuera, Carlos A; Coraça-Huber, Débora C; Choe, Hyonmin; Jennings, Jessica Amber; Joshi, Manjari; Li, William T; Noble, Philip C; Phillips, K Scott; Pottinger, Paul S; Restrepo, Camilo; Rohde, Holger; Schaer, Thomas P; Shen, Hao; Smeltzer, Mark; Stoodley, Paul; Webb, Jason C J; Witsø, Eivind.

In: J ORTHOP RES, Vol. 37, No. 5, 05.2019, p. 1007-1017.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Saeed, K, McLaren, AC, Schwarz, EM, Antoci, V, Arnold, WV, Chen, AF, Clauss, M, Esteban, J, Gant, V, Hendershot, E, Hickok, N, Higuera, CA, Coraça-Huber, DC, Choe, H, Jennings, JA, Joshi, M, Li, WT, Noble, PC, Phillips, KS, Pottinger, PS, Restrepo, C, Rohde, H, Schaer, TP, Shen, H, Smeltzer, M, Stoodley, P, Webb, JCJ & Witsø, E 2019, '2018 international consensus meeting on musculoskeletal infection: Summary from the Biofilm Workgroup and consensus on Biofilm related Musculoskeletal Infections', J ORTHOP RES, vol. 37, no. 5, pp. 1007-1017. https://doi.org/10.1002/jor.24229

APA

Saeed, K., McLaren, A. C., Schwarz, E. M., Antoci, V., Arnold, W. V., Chen, A. F., Clauss, M., Esteban, J., Gant, V., Hendershot, E., Hickok, N., Higuera, C. A., Coraça-Huber, D. C., Choe, H., Jennings, J. A., Joshi, M., Li, W. T., Noble, P. C., Phillips, K. S., ... Witsø, E. (2019). 2018 international consensus meeting on musculoskeletal infection: Summary from the Biofilm Workgroup and consensus on Biofilm related Musculoskeletal Infections. J ORTHOP RES, 37(5), 1007-1017. https://doi.org/10.1002/jor.24229

Vancouver

Saeed K, McLaren AC, Schwarz EM, Antoci V, Arnold WV, Chen AF et al. 2018 international consensus meeting on musculoskeletal infection: Summary from the Biofilm Workgroup and consensus on Biofilm related Musculoskeletal Infections. J ORTHOP RES. 2019 May;37(5):1007-1017. https://doi.org/10.1002/jor.24229

Bibtex

@article{83601f9492ec4ffb97a0d9ecf5bef014,
title = "2018 international consensus meeting on musculoskeletal infection: Summary from the Biofilm Workgroup and consensus on Biofilm related Musculoskeletal Infections",
abstract = "Biofilm-associated implant-related bone and joint infections are clinically important due to the extensive morbidity, cost of care and socioeconomic burden that they cause. Research in the field of biofilms has expanded in the past two decades, however, there is still an immense knowledge gap related to many clinical challenges of these biofilm-associated infections. This subject was assigned to the Biofilm Workgroup during the second International Consensus Meeting on Musculoskeletal Infection held in Philadelphia USA (ICM 2018) (https://icmphilly.com). The main objective of the Biofilm Workgroup was to prepare a consensus document based on a review of the literature, prepared responses, discussion, and vote on thirteen biofilm related questions. The Workgroup commenced discussing and refining responses prepared before the meeting on day one using Delphi methodology, followed by a tally of responses using an anonymized voting system on the second day of ICM 2018. The Working group derived consensus on information about biofilms deemed relevant to clinical practice, pertaining to: (1) surface modifications to prevent/inhibit biofilm formation; (2) therapies to prevent and treat biofilm infections; (3) polymicrobial biofilms; (4) diagnostics to detect active and dormant biofilm in patients; (5) methods to establish minimal biofilm eradication concentration for biofilm bacteria; and (6) novel anti-infectives that are effective against biofilm bacteria. It was also noted that biomedical research funding agencies and the pharmaceutical industry should recognize these areas as priorities. {\textcopyright} 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res.",
keywords = "Journal Article",
author = "Kordo Saeed and McLaren, {Alex C} and Schwarz, {Edward M} and Valentin Antoci and Arnold, {William V} and Chen, {Antonia F} and Martin Clauss and Jaime Esteban and Vanya Gant and Edward Hendershot and Noreen Hickok and Higuera, {Carlos A} and Cora{\c c}a-Huber, {D{\'e}bora C} and Hyonmin Choe and Jennings, {Jessica Amber} and Manjari Joshi and Li, {William T} and Noble, {Philip C} and Phillips, {K Scott} and Pottinger, {Paul S} and Camilo Restrepo and Holger Rohde and Schaer, {Thomas P} and Hao Shen and Mark Smeltzer and Paul Stoodley and Webb, {Jason C J} and Eivind Wits{\o}",
note = "This article is protected by copyright. All rights reserved.",
year = "2019",
month = may,
doi = "10.1002/jor.24229",
language = "English",
volume = "37",
pages = "1007--1017",
journal = "J ORTHOP RES",
issn = "0736-0266",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

RIS

TY - JOUR

T1 - 2018 international consensus meeting on musculoskeletal infection: Summary from the Biofilm Workgroup and consensus on Biofilm related Musculoskeletal Infections

AU - Saeed, Kordo

AU - McLaren, Alex C

AU - Schwarz, Edward M

AU - Antoci, Valentin

AU - Arnold, William V

AU - Chen, Antonia F

AU - Clauss, Martin

AU - Esteban, Jaime

AU - Gant, Vanya

AU - Hendershot, Edward

AU - Hickok, Noreen

AU - Higuera, Carlos A

AU - Coraça-Huber, Débora C

AU - Choe, Hyonmin

AU - Jennings, Jessica Amber

AU - Joshi, Manjari

AU - Li, William T

AU - Noble, Philip C

AU - Phillips, K Scott

AU - Pottinger, Paul S

AU - Restrepo, Camilo

AU - Rohde, Holger

AU - Schaer, Thomas P

AU - Shen, Hao

AU - Smeltzer, Mark

AU - Stoodley, Paul

AU - Webb, Jason C J

AU - Witsø, Eivind

N1 - This article is protected by copyright. All rights reserved.

PY - 2019/5

Y1 - 2019/5

N2 - Biofilm-associated implant-related bone and joint infections are clinically important due to the extensive morbidity, cost of care and socioeconomic burden that they cause. Research in the field of biofilms has expanded in the past two decades, however, there is still an immense knowledge gap related to many clinical challenges of these biofilm-associated infections. This subject was assigned to the Biofilm Workgroup during the second International Consensus Meeting on Musculoskeletal Infection held in Philadelphia USA (ICM 2018) (https://icmphilly.com). The main objective of the Biofilm Workgroup was to prepare a consensus document based on a review of the literature, prepared responses, discussion, and vote on thirteen biofilm related questions. The Workgroup commenced discussing and refining responses prepared before the meeting on day one using Delphi methodology, followed by a tally of responses using an anonymized voting system on the second day of ICM 2018. The Working group derived consensus on information about biofilms deemed relevant to clinical practice, pertaining to: (1) surface modifications to prevent/inhibit biofilm formation; (2) therapies to prevent and treat biofilm infections; (3) polymicrobial biofilms; (4) diagnostics to detect active and dormant biofilm in patients; (5) methods to establish minimal biofilm eradication concentration for biofilm bacteria; and (6) novel anti-infectives that are effective against biofilm bacteria. It was also noted that biomedical research funding agencies and the pharmaceutical industry should recognize these areas as priorities. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res.

AB - Biofilm-associated implant-related bone and joint infections are clinically important due to the extensive morbidity, cost of care and socioeconomic burden that they cause. Research in the field of biofilms has expanded in the past two decades, however, there is still an immense knowledge gap related to many clinical challenges of these biofilm-associated infections. This subject was assigned to the Biofilm Workgroup during the second International Consensus Meeting on Musculoskeletal Infection held in Philadelphia USA (ICM 2018) (https://icmphilly.com). The main objective of the Biofilm Workgroup was to prepare a consensus document based on a review of the literature, prepared responses, discussion, and vote on thirteen biofilm related questions. The Workgroup commenced discussing and refining responses prepared before the meeting on day one using Delphi methodology, followed by a tally of responses using an anonymized voting system on the second day of ICM 2018. The Working group derived consensus on information about biofilms deemed relevant to clinical practice, pertaining to: (1) surface modifications to prevent/inhibit biofilm formation; (2) therapies to prevent and treat biofilm infections; (3) polymicrobial biofilms; (4) diagnostics to detect active and dormant biofilm in patients; (5) methods to establish minimal biofilm eradication concentration for biofilm bacteria; and (6) novel anti-infectives that are effective against biofilm bacteria. It was also noted that biomedical research funding agencies and the pharmaceutical industry should recognize these areas as priorities. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res.

KW - Journal Article

U2 - 10.1002/jor.24229

DO - 10.1002/jor.24229

M3 - SCORING: Journal article

C2 - 30667567

VL - 37

SP - 1007

EP - 1017

JO - J ORTHOP RES

JF - J ORTHOP RES

SN - 0736-0266

IS - 5

ER -